Skip to main content

Histogen Inc.

HSTODelisted Oct 12, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001383701

Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
9
Q3 2023, −4 vs. previous quarter
13F value
$9.53K
Reported value at the end of Q3 2023
Superinvestors holding
0
At the end of Q3 2023

Superinvestors holding HSTO, Q3 2023

Go to the superinvestors tab

No superinvestor reported holding HSTO at the end of Q3 2023.

Latest insider trades

Open-market purchases and sales by Histogen Inc. insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Histogen Inc. insiders are on file.

Top 10 13F holders, Q3 2023

The largest institutional positions in Histogen Inc. at the end of Q3 2023; share changes are against Q2 2023.

See all 9 holders
Institutions holding HSTO in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Synovus Financial Corp10,050$5.17K0.00%00.0%Unchanged
Morgan Stanley8,000$4.12K0.00%−8,100−50.3%Reduced
Advisor Group Holdings, Inc.275$1420.00%00.0%Unchanged
UBS Group AG89$460.00%+89New
Wells Fargo & Company62$320.00%+31+100.0%Added
Global Retirement Partners, LLC15$100.00%00.0%Unchanged
Compagnie Lombard Odier SCmA15$80.00%00.0%Unchanged
Royal Bank of Canada15$00.00%00.0%Unchanged
Highlander Capital Management, LLC17$00.00%+17New